Introduction

NAD+ is having a moment. You will find it in longevity podcasts, biohacking forums, anti-aging clinics, and supplement aisles, usually surrounded by bold claims about reversing aging, restoring energy, and repairing DNA.

Some of those claims are better supported than others. What is not in dispute is this: NAD+ is one of the most important molecules in the human body, its levels fall significantly as we age, and that decline has real biological consequences.

What is very much in dispute is how best to raise those levels, and whether injectable NAD+ is meaningfully better than oral supplementation, or whether it is an expensive upgrade with limited additional benefit for most people.

I am Dr. Aleksander Kanevsky, a Doctor of Chiropractic and Certified Functional Medicine Practitioner at Atlant Chiropractic in Midtown Manhattan. My role is not to prescribe any of these therapies. It is to give you an honest, clinically grounded explanation of what the science actually shows so you can have a more informed conversation with your physician.

If you are new to the broader world of peptides and longevity therapies, start here first: Peptides 101: What They Are, Why Everyone Is Talking About Them, and How to Use Them Safely (https://atlantchiropractic.com/peptides-101-safe-use-benefits-metabolic-health/).

What Is NAD+ and Why Does It Matter?

NAD+, or nicotinamide adenine dinucleotide, is a coenzyme found in every living cell in your body. It is not a hormone, not a peptide in the traditional sense, and not a vitamin, though it is synthesized partly from niacin (vitamin B3). It is a molecular workhorse that participates in hundreds of enzymatic reactions, with particular importance in two areas.

The first is energy production. NAD+ acts as an electron carrier in the metabolic pathways that convert food into ATP, the currency your cells use to do everything. Without adequate NAD+, mitochondrial function becomes less efficient. The result is not always dramatic fatigue. More often it is a subtle but persistent loss of resilience: slower recovery, less metabolic flexibility, reduced capacity to handle physical and cognitive demands.

The second is cellular maintenance. NAD+ is the essential cofactor for a family of enzymes called sirtuins and another called PARPs. Sirtuins regulate gene expression, stress resistance, and inflammation. PARPs are your DNA repair enzymes. Both systems depend on NAD+ to function. When NAD+ levels are low, both systems run poorly.

Here is the part that matters clinically: NAD+ levels decline with age in a substantial and well-documented way. Research published in 2025 in Nature Metabolic Health and Disease confirms that declining NAD+ is associated with mitochondrial dysfunction, genomic instability, cognitive decline, sarcopenia, and metabolic disease. A 2025 study from Medical News Today further established that mitochondria act as a reservoir for NAD+, actively supplying it to cells under stress, and that when this reservoir is depleted, the downstream effects touch almost every tissue with high energy demands, particularly the brain and skeletal muscle.

Some research suggests NAD+ levels can fall by anywhere from 10 to 80 percent in various tissues across the aging process. That is not a narrow correction. It is a fundamental change in how efficiently your cells operate.

The Oral Option: NMN and NR

When most people start exploring NAD+ supplementation, they start with oral capsules. The two most studied oral forms are NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). Neither is NAD+ itself. Both are precursors, meaning the body converts them into NAD+ through the salvage pathway, a series of enzymatic steps that happen primarily in the liver and other tissues.

This distinction matters more than most supplement marketing acknowledges.

NMN and NR are genuinely bioavailable when taken orally. Published research from the PMC database confirms that both are converted into NAD+ in human cells, with blood levels peaking roughly three to eight hours after oral intake. Multiple clinical trials using NMN and NR in aging populations have shown they can meaningfully raise circulating NAD+ levels. This is not speculative. The clinical trial database on oral precursors is now reasonably robust, with over 18 published human trials on oral NAD+ precursor administration.

The honest limitation of oral supplementation is threefold.

First, the conversion process is not direct. NMN and NR must be metabolized into NAD+ before reaching tissues. That pathway is rate-limited by an enzyme called NAMPT, and NAMPT activity itself declines with age. In other words, the older you are, the less efficiently your body converts oral precursors into usable NAD+.

Second, a meaningful portion of orally delivered NAD+ is degraded in the gastrointestinal tract before absorption. The molecule is large enough and unstable enough that GI exposure reduces its effective dose. Liposomal and enteric-coated oral formulations have been developed specifically to address this, with some evidence of improved absorption, but the data remains preliminary.

Third, even where oral precursors successfully raise blood NAD+ levels, a genuine scientific debate exists about how much of that translates to intracellular NAD+ replenishment, which is where the therapeutic effect actually lives. As one researcher noted, if injected or oral NAD+ cannot enter cells intact, the plasma bioavailability number does not tell the whole story.

None of this means oral NAD+ supplementation does not work. For people with mild to moderate age-related decline, adequate gut absorption, and a maintenance rather than restoration goal, oral NMN or NR is a reasonable, lower-cost, and well-tolerated starting point.

The Injectable Option: Subcutaneous and IV NAD+

Injectable NAD+ takes a fundamentally different approach. Rather than relying on conversion from a precursor and surviving GI transit, injectable NAD+ delivers the molecule directly into the bloodstream, bypassing the digestive system entirely.

IV NAD+ infusion, the format used in clinical settings, achieves 100 percent bioavailability. A 2023 pharmacokinetic study found that IV administration produced peak plasma NAD+ levels roughly six times higher than matched oral dosing, with tissue uptake detectable in muscle biopsies within hours. For acute clinical applications, post-viral recovery, neurological support, addiction recovery protocols, and high-performance athletes managing accumulated physiological stress, this level of rapid saturation can make a real difference.

Subcutaneous NAD+ injection, the format available through compounding pharmacies and physician-reviewed telehealth platforms, occupies a practical middle ground. It bypasses first-pass metabolism and GI degradation, providing a more sustained absorption profile than IV infusion with significantly higher bioavailability than oral supplements. A 2026 Frontiers in Aging pilot study examining IV NAD+ versus NR infusion confirmed good tolerability for parenteral (injectable) NAD+ administration with no adverse events reported up to 30 days post-infusion.

The clinical benefits most consistently reported with injectable NAD+ include improvements in energy and mental clarity within days to weeks (significantly faster than oral forms), support for post-exertion recovery, and particular utility for patients with compromised gastrointestinal absorption who cannot rely on the oral pathway. People with inflammatory bowel disease, significant gut dysbiosis, or a history of intestinal permeability issues are exactly the patients for whom injectable delivery makes the most clinical sense, because the oral route is unreliable for them regardless of dose.

The honest limitation of injectable NAD+ is that the human clinical trial base, while growing, is still less mature than the oral precursor literature. Most of the evidence for injectable formats comes from pharmacokinetic studies, mechanistic research, and clinical observation rather than large-scale double-blind randomized controlled trials. The research is moving quickly, with Phase II trials of parenteral NAD+ in long COVID and early Alzheimer’s disease actively recruiting as of 2025, but the evidentiary gap is real and worth acknowledging.

Cost is also a genuine consideration. Injectable NAD+ through a telehealth platform typically costs significantly more than oral NMN or NR supplementation. Whether that cost is justified depends entirely on your individual situation, your absorption capacity, and how urgently you need to restore rather than maintain.

The Nasal Spray Option

A third delivery format worth mentioning is NAD+ nasal spray, available through some compounding pharmacies and telehealth platforms including EllieMD. Nasal delivery bypasses the gastrointestinal tract and offers a direct route toward the CNS via the olfactory mucosa, which is why it has particular appeal for patients focused on cognitive function, brain fog, and neurological applications. Bioavailability through nasal delivery is higher than oral but lower than injectable. For patients who are needle-averse and have a primarily cognitive or neurological goal, nasal spray represents a reasonable middle-ground option. The evidence base specific to nasal NAD+ is less developed than either oral or IV formats, so clinical expectations should be calibrated accordingly.

NAD+ and the Functional Medicine Framework

From a functional medicine standpoint, NAD+ restoration is not a standalone intervention. It is most effective when understood in the context of why NAD+ has declined in the first place.

Chronic inflammation accelerates NAD+ consumption because the PARP enzyme system that repairs DNA damage is one of the largest consumers of NAD+ in the body. A patient with significant inflammatory burden is burning through NAD+ faster than someone without it. Simply topping up NAD+ without addressing the inflammatory driver is a maintenance strategy at best.

Similarly, mitochondrial dysfunction and NAD+ decline are tightly coupled. Raising NAD+ levels supports mitochondrial function, but mitochondria that are already severely compromised by oxidative stress, toxin exposure, or chronic sleep deprivation will not respond as robustly as those in a better maintained cellular environment.

This is the pattern I see most consistently in functional medicine practice: patients who address their foundational health, sleep quality, inflammatory load, gut integrity, and nutritional cofactors first, and then add NAD+ support, get dramatically better results than those who try to skip the foundational work and go straight to the intervention.

NAD+ amplifies a system that is functional. It has a harder time compensating for one that is not.

For a deeper look at how this principle applies to peptide therapies generally, see: Peptides Are Signals, Not Solutions: Why They Work for Some and Fail for Others (https://atlantchiropractic.com/peptides-are-signals-not-solutions/).

Who Is a Good Candidate for NAD+ Injection Specifically?

Based on the clinical picture, injectable NAD+ makes the most sense for the following patient profiles:

Adults over 45 experiencing significant fatigue or cognitive decline that has not responded adequately to foundational interventions, including optimized sleep, nutrition, and mitochondrial support through B vitamins and magnesium.

Patients with documented gut dysfunction, inflammatory bowel disease, significant dysbiosis, or a history of intestinal permeability, for whom oral absorption is unreliable regardless of the supplement quality.

Post-viral recovery patients, particularly those managing long COVID sequelae, where the evidence for parenteral NAD+ in neurological and fatigue applications is among the most clinically promising.

High-performance individuals managing significant physiological stress loads who need faster restoration rather than gradual maintenance.

Patients already on a longevity protocol who want to move from maintenance to active restoration of NAD+ levels, particularly if oral precursors have plateaued in effect.

Oral NMN or NR remains a sensible starting point for adults in their 30s and 40s with moderate decline, good gut function, and a maintenance or prevention-oriented goal. It is lower cost, well-tolerated, and the evidence base for raising blood NAD+ levels is solid.

How to Access NAD+ Injectable Through a Physician-Reviewed Platform

As a chiropractor and functional medicine practitioner, prescribing is outside my scope. My role is to prepare you to have a well-informed conversation with a physician.

For patients ready to explore NAD+ injection or nasal spray, I point them toward physician-reviewed telehealth platforms that conduct a proper health intake before making prescribing decisions. EllieMD (https://elliemd.com) offers both NAD+ injectable and NAD+ nasal spray, prescribed by licensed physicians with home delivery.

Disclosure: I may receive a referral commission if you use this link. I recommend this platform because their physician oversight model and product range align with the standard of care I believe patients deserve. That does not change based on the commission.

For the full picture of how NAD+ fits into a broader longevity peptide protocol, read through our complete peptide education series at: https://atlantchiropractic.com/category/peptides/

Key Takeaways

NAD+ is a coenzyme essential for mitochondrial energy production, DNA repair, and cellular resilience. Its levels decline significantly with age, and that decline is now recognized as a meaningful driver of biological aging.

Oral NAD+ precursors like NMN and NR are genuinely bioavailable, well-tolerated, and backed by a solid base of human clinical trials. Their limitation is that conversion efficiency declines with age and GI degradation reduces effective dose.

Injectable NAD+ bypasses the digestive system entirely, delivering the molecule directly to the bloodstream with substantially higher bioavailability and faster onset. It is the better option for patients with gut dysfunction, significant decline, post-viral recovery needs, or those who have plateaued on oral supplementation.

The nasal spray format offers an accessible middle ground for patients focused on cognitive and neurological applications who prefer to avoid injections.

NAD+ works best when foundational health has been addressed first. Chronic inflammation, poor sleep, and mitochondrial stress blunt the response to any form of NAD+ supplementation.

The evidence base is growing rapidly, but injectable NAD+ still has fewer large-scale randomized trials than oral precursors. Clinical decision-making should reflect that distinction.

Frequently Asked Questions About NAD+ Injection vs Oral

What is NAD+ and why do levels decline with age?

NAD+ is nicotinamide adenine dinucleotide, a coenzyme involved in hundreds of enzymatic reactions, most critically mitochondrial energy production and DNA repair. Levels decline with age due to increased cellular stress, reduced synthesis efficiency, and elevated consumption by DNA repair enzymes. Research published in 2025 links this decline to mitochondrial dysfunction, cognitive decline, sarcopenia, and metabolic disease.

Is NAD+ injection better than oral supplements?

For most adults with moderate age-related decline and good gut function, oral NMN or NR is a reasonable starting point. Injectable NAD+ offers significantly higher bioavailability and faster onset, making it the better clinical choice for patients with gut absorption issues, significant NAD+ depletion, post-viral recovery needs, or those who have plateaued on oral supplementation. The right form depends on your individual situation.

What is the difference between NAD+, NMN, and NR?

NAD+ is the active molecule your cells use directly. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors, meaning your body converts them into NAD+ through a series of enzymatic steps. Injectable NAD+ delivers the molecule directly. Oral NMN and NR deliver precursors that require conversion, which becomes less efficient with age.

How quickly does NAD+ injection work?

Most patients report improved energy and mental clarity within days to two weeks of starting injectable NAD+, significantly faster than oral supplementation, which typically takes four to eight weeks for noticeable effect. Individual response varies based on how depleted NAD+ levels are and the underlying state of mitochondrial health.

Does NAD+ injection have side effects?

Injectable NAD+ is generally well-tolerated. The most commonly reported side effects are mild and transient: injection site reactions, flushing, headache, or nausea. IV infusion has historically been associated with a higher rate of transient discomfort during administration, which is one reason subcutaneous injection is often preferred for at-home protocols. A 2026 Frontiers in Aging pilot study reported no adverse events up to 30 days post-infusion.

Who should not use NAD+ supplementation?

Patients with active malignancy should use caution, as NAD+ supports cellular proliferation and the implications for tumor biology are not fully established. Pregnancy and breastfeeding are contraindications. Anyone with a known allergy to niacin or related B3 compounds should be evaluated carefully. Patients with significant cardiovascular instability should use IV formats only under close clinical supervision.

Can I take NAD+ with other peptides or supplements?

NAD+ is commonly included in broader longevity protocols alongside growth hormone secretagogues like sermorelin, immune peptides like thymosin alpha-1, and foundational supplements including magnesium, B vitamins, and CoQ10. Specific combination protocols should be determined by your prescribing physician based on your labs and health goals. Read our Sermorelin vs HGH post for context on how growth hormone peptides fit into the same longevity framework: https://atlantchiropractic.com/sermorelin-vs-hgh-what-patients-need-to-know/

How does NAD+ relate to mitochondrial health?

Mitochondria act as a reservoir for NAD+, actively supplying it to cells under metabolic stress. When NAD+ levels fall, mitochondrial function becomes less efficient, ATP production declines, and cells become less capable of repairing oxidative damage. Raising NAD+ levels through supplementation or injection supports the mitochondrial machinery that underlies energy production, recovery, and healthy aging at the cellular level.

References

1. Campagna G, et al. The role of NAD+ metabolism and its modulation of mitochondria in aging and disease. npj Metabolic Health and Disease. 2025 Jun 18. https://www.nature.com/articles/s44324-025-00067-0
2. Radenkovic D, Reason, Verdin E. Clinical Evidence for Targeting NAD Therapeutically. Pharmaceuticals (Basel). 2020;13(9):247. https://pmc.ncbi.nlm.nih.gov/articles/PMC7558103/
3. Gilmour BC, et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Frontiers in Aging. 2026 Jan 7. https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2026.1652582/full
4. She J, Sheng R, Qin ZH. Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors. Advances in Pharmacology. 2021. Referenced in: Olympia Pharmacy. NAD+ Oral vs Injection: What’s the Difference? https://www.olympiapharmacy.com/blog/nad-oral-vs-injection/
5. Hawkins M, et al. Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen+ IV and NAD+ IV in healthy adults. medRxiv. 2024. https://www.medrxiv.org/content/10.1101/2024.06.06.24308565.full.pdf
6. Ziegler M, et al. Slowing aging: Scientists discover how NAD energizes cells. Medical News Today. 2025 Feb 1. https://www.medicalnewstoday.com/articles/stopping-nad-depletion-mitochondria-key-slowing-down-aging-supplements
7. HealthSpan Research. NAD+ Injections Benefits: How They Compare to IV and Oral Supplements. 2026 Apr 19. https://www.gethealthspan.com/research/article/nad-injections-benefits-quaw

FDA DISCLAIMER

The information provided in this article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease or health condition. NAD+ therapy in injectable form is a prescription intervention that should only be pursued under the supervision of a licensed healthcare provider. Aleksander Kanevsky, DC, CFMP, is a licensed chiropractor and certified functional medicine practitioner. Chiropractors are not licensed to prescribe medications. Nothing in this article constitutes a medical recommendation or prescription. Oral NMN and NR supplements are available without a prescription but individual results vary and the FDA has not approved these compounds for any specific medical condition. Always consult a qualified physician before beginning any new therapeutic protocol.